Navigation Links
Director's Forum: PEPFAR and the Global AIDS Response
Date:9/17/2007

To be webcast live at http://www.wilsoncenter.org/globalhealth

WASHINGTON, Sept. 17 /PRNewswire-USNewswire/ -- Earlier this year, President George W. Bush called for a reauthorization of the President's Emergency Plan for AIDS Relief (PEPFAR), which is set to expire at the end of fiscal year 2008. The plan calls for an increase in funding from the initial 2003 commitment of $15 billion to $30 billion over the next five years.

On September 20, 2007, the Woodrow Wilson Center's Global Health Initiative and Environmental Change and Security Program will co-host a discussion on PEPFAR principles and the global AIDS response, featuring Dr. Peter Piot, Executive Director of UNAIDS and Under Secretary-General of the United Nations, U.S. Representative Nita M. Lowey of New York's 18th District, and Kent R. Hill, Assistant Administrator for the Bureau for Global Health at the U.S. Agency for International Development (USAID).

If you are unable to attend, this event will be webcast live at http://www.wilsoncenter.org/globalhealth.

What: Director's Forum: PEPFAR and the Global AIDS Response

Who: Dr. Peter Piot, Executive Director, UNAIDS, and Under

Secretary-General, United Nations; The Honorable Nita M.

Lowey, U.S. Representative, 18th District, New York, and

Chairwoman of the State, Foreign Operations, and Related

Programs Subcommittee on Appropriations; and Kent R. Hill,

Assistant Administrator for Global Health, USAID

When: Thursday, September 20, 2007, 10:00 - 11:30 a.m.

Where: Woodrow Wilson Center, 6th Floor Flom Auditorium

The Woodrow Wilson Center is located in the Ronald Reagan

Building and International Trade Center at 1300 Pennsylvania

Avenue, N.W.

S
'/>"/>

SOURCE Woodrow Wilson International Center for Scholars
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The International Myeloma Foundation Says Data Reported at a Global Medical Meeting in Greece Demonstrates Improved Survival for a Wide Range of Myeloma Patients
2. New Report Looking at Chiral Technologies Analyzes the Global Market Growth Forecasts Driven By Two Very Important Components as Single Isomer Drugs and Single Enantiomer Pharmaceuticals
3. New Study Reveals Limitations of a Complex and Challenging Global Tuberculosis Drug Marketplace
4. Global Rabies Treatment May be Possible with NanoViricides Drugs
5. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
6. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
7. Trexima (Sumatriptan/Naproxen Sodium) Demonstrated Migraine-Free Response Across Multiple Attacks
8. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
9. Data Demonstrated Metastatic Melanoma Response to Investigational Immunotherapy Ipilimumab
10. Ontak (denileukin diftitox) Achieves 49.1% Overall Response Rate in Phase III Trial of Cutaneous T-Cell Lymphoma (CTCL)
11. Introgen Reports Updated Phase 2 Advexin Data Correlating Improved Survival, Tumor Responses and Predictive p53 Biomarker
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Dohmen Company CEO Cynthia LaConte is the ... Commerce,s annual ,Future 50, Awards luncheon, to be held ... 50, Awards highlights the achievements of 50 local, fast-growing ... the seven-county Milwaukee region. ... home for more than 150 years, and LaConte ...
(Date:9/4/2015)... DIEGO , Sept. 4, 2015  Orexigen® Therapeutics, Inc. ... a corporate overview at the Wells Fargo Securities 2015 Healthcare ... scheduled for Thursday, September 10 th at 2:30 p.m. ... replay of the discussion, please visit the Investors section of ... will be available for 14 days after the event.  ...
(Date:9/4/2015)... 2015  Allergan plc (NYSE: AGN ) a leading ... CEO and President of Allergan, will provide an overview and ... Healthcare Conference 2015 in New York, NY ... The presentation will take place on Thursday, September 17, ... New York, 109 East 42nd Street, New York, ...
Breaking Medicine Technology:Dohmen CEO Cynthia LaConte to Keynote MMAC 'Future 50' Awards Luncheon 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 2Allergan to Present at Morgan Stanley Global Healthcare Conference 2015 3
(Date:9/4/2015)... , ... September 04, 2015 , ... ... Insight Product Development has effectively doubled the size of its annual health tech ... medical device and digital health startups to compete for cash and prizes to ...
(Date:9/4/2015)... Denver, CO (PRWEB) , ... September 04, 2015 , ... ... highlights the ways in which a lack of funding for sidewalks, bike paths, and ... to the report, while the Denver region spends billions of dollars to expand public ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... The Providence ... to learn more about their fertility and egg freezing. , Date and Time: October ... 6PM to 7PM , This hip and informative event will discuss the basics of ...
(Date:9/4/2015)... (PRWEB) , ... September 04, 2015 , ... ... and the surrounding communities, is launching a charity effort to provide for the ... referred to as an enlarged heart, restrictive cardiomyopathy often leads to diastolic dysfunction ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... Products Association (CHPA) joint meeting of its Product, Quality and Manufacturers, Dietary Supplements ... handling rules constantly evolving in the consumer goods industry, it can be difficult ...
Breaking Medicine News(10 mins):Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Missed Connections in Metro Denver Transit 2Health News:The Providence Fertility Center to Host Fertility Cocktail Hour on October 8, 2015 at Waterman Grille for Women Who Wish to Learn About Their Fertility and Egg Freezing 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3
... The ... flow, circulation and absorption throughout the surface of the skin and scalp. A new line ... fast relief for a variety of topical conditions affecting the skin, scalp and feet. ... Schenectady, NY (PRWEB) October 26, ...
... , ... MedAssets Enter Three Year GPO Agreement , ... Wichita, KS (PRWEB) October 26, 2009 -- MedAppz, a leading ... Supply Chain Systems, today announced a multiyear agreement to offer EHR software as a ...
... ... NCBI Viral Genomes and VBRC databases enable researchers to quickly and effectively use these ... ... of new tutorial suites on Integrated Microbial Genomes (IMG), Integrated Microbial Genomes with Microbiome ...
... WASHINGTON, Oct. 25, 2009 Arena Pharmaceuticals, Inc. ... the pivotal BLOOM (Behavioral modification and Lorcaserin for ... lorcaserin significantly increased excess weight loss, improved markers ... not associated with depression or suicidal ideation. Additional ...
... by scientists at the Oklahoma Medical Research Foundation could help ... car crashes or on the battlefield. The work also holds ... a paper published online today in the advance edition of ... Esmon, Ph.D., with co-authors Florea Lupu, Ph.D., and Jun Xu, ...
... Today, LA,s BEST After School Enrichment Program and the ... children and their families about the importance of drinking water ... and recycling more plastics. , As part of the program, ... that they can use throughout the day, challenging children to ...
Cached Medicine News:Health News:Caffeinated Cayenne Pepper Body Sprays Relieve Common Skin and Scalp Problems 2Health News:Caffeinated Cayenne Pepper Body Sprays Relieve Common Skin and Scalp Problems 3Health News:MedAppz Signs Agreement with MedAssets to Offer SAAS-based Electronic Health Record to MedAssets' Non-acute Customers 2Health News:New Online Tutorials for IMG, IMG/M, NCBI Viral Genomes and VBRC 2Health News:New Online Tutorials for IMG, IMG/M, NCBI Viral Genomes and VBRC 3Health News:New Online Tutorials for IMG, IMG/M, NCBI Viral Genomes and VBRC 4Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 2Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 3Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 4Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 5Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 6Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 7Health News:Positive Data from Arena Pharmaceuticals' Pivotal BLOOM Trial Demonstrate that Lorcaserin Significantly Improved Markers of Cardiovascular Risk and Glycemic Parameters and was not Associated with Depression or Suicidal Ideation 8Health News:Oklahoma scientists discover promising new path for treating traumas 2Health News:LA's BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 2Health News:LA's BEST Teams Up With American Chemistry Council to Educate Kids About the Benefits of a Healthy Lifestyle and a Healthy Environment 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: